Skip to content
LexBuild

Consumer Roundtable; Notice of Meeting

---
identifier: "/us/fr/00-29424"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Consumer Roundtable; Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "00-29424"
section_name: "Consumer Roundtable; Notice of Meeting"
positive_law: false
currency: "2000-11-16"
last_updated: "2000-11-16"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "00-29424"
document_type: "notice"
publication_date: "2000-11-16"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "65 FR 69318"
fr_volume: 65
fr_action: "Notice."
---

#  Consumer Roundtable; Notice of Meeting

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

The Food and Drug Administration (FDA) is announcing the following meeting: Consumer roundtable to discuss consumer protection priorities for the agency. The roundtable will provide an opportunity for FDA to engage in an open dialogue with individual consumer stakeholders on a variety of regulatory and consumer oriented issues. The roundtable is part of the agency's ongoing consultation with stakeholders.

*Date and Time:* The meeting will be held on December 13, 2000, 9 a.m. to 4 p.m.

*Location:* The meeting will be held at the Penthouse Conference Room, Hubert H. Humphrey Bldg., 200 Independence Ave. SW., Washington, DC.

*Contact:* Karen R. Mahoney, Office of Consumer Affairs (HFE-88), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4393, FAX 301-827-2866, e-mail: *[email protected]* .

*Registration:* Preregistration is required as space is limited. Send registration information (including name, title, organization name, address, telephone, fax number, and e-mail) to the contact person by December 6, 2000.

If you need special accommodations due to a disability, please contact Karen R. Mahoney (address above) at least 7 days in advance.

Background information on this meeting will be available on the FDA Internet site at *http://www.fda.gov/opacom/hpmeetings.html* .

*Transcripts:* Transcripts of the meeting may be requested in writing from the Freedom of Information Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, approximately 15 working days after the meeting at a cost of 10 cents per page.

Dated: November 9, 2000.

Margaret M. Dotzel,

Associate Commissioner for Policy.